{"name":"Aesculap Biologics, LLC","slug":"aesculap-biologics-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NOVOCART 3D","genericName":"NOVOCART 3D","slug":"novocart-3d","indication":"Articular cartilage defects of the knee","status":"phase_3"}]}],"pipeline":[{"name":"NOVOCART 3D","genericName":"NOVOCART 3D","slug":"novocart-3d","phase":"phase_3","mechanism":"NOVOCART 3D is an autologous engineered cartilage construct that regenerates damaged articular cartilage by combining patient's own cells with a 3D scaffold.","indications":["Articular cartilage defects of the knee"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNbTczZUxLZUJ6Z01BeDZ5YWxjRGRLd1NGUkN4cVQyTzA2S3dWd2oxVl9jM0FCNTJxTm1HTjNXWTVqaktoMEx1VE4wVG8xY0x3WWo2dGJwVndIWmExVXBabF9yaWFpSmh5VTlZRkdLY2pRckRUQ0lrVWJSellWcC05QkNrOTRzUWxVdk9udHBFVTdyXzkySGNybWN4N2dXUGJvaEZqSGFRSUdHRm5H?oc=5","date":"2024-06-07","type":"deal","source":"TMX Newsfile","summary":"Octane Medical Acquires B. Braun's Global Orthobiologics Business - TMX Newsfile","headline":"Octane Medical Acquires B. Braun's Global Orthobiologics Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPeTR3cWJHMy1FRU4wREFsSzRGcmQ3WEdISjNkMWNXazlfYzlCZVBDRHhwVERCMmkwLW4wek43WDlvLVlodC1DSUw5T3dTTnVZTFc1NmJrcXNGalB0bHNCbkhCbnpPZHpjN2hvNzVVbTVrZW9ZT0s1LVBlOHRNMEQydThFN3hNVXFEMWxURnVPLVdOYml3Q05zQ0RtcWpGTnNuRUQ3WFZld21ramE3aGdETkR4cE54MjZGU0FGdnRUbHk0RmJhUDRONVFtQ2Z5bHNVazFTdUxNdlcwbWNIeHhEbjBrcjVsYzA?oc=5","date":"2021-04-06","type":"trial","source":"BioSpace","summary":"Stanford Medicine Joins Pivotal Phase 3 Clinical Trial of NOVOCART® 3D for Patients with Articular Cartilage Defects of the Knee - BioSpace","headline":"Stanford Medicine Joins Pivotal Phase 3 Clinical Trial of NOVOCART® 3D for Patients with Articular Cartilage Defects of ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgJBVV95cUxQWkc0aVgzMHJCbkxrRGQ2NGpXSDlHQk1iNUtGZkhJUHB1Z1NFTkdQRnBJaEU5OGlFUE8tMmJ2VnBsc2NQZkUwOHJYQURZTmluYU93RndubVpJSWVZVkI2WmN2a0dsZjVYNkpqY19nTUoyVFM3TUVQTUNWbmxSVmdYZVhuSkp6VU9MWGV4eXd2Q1JzaXk0THBiOTJwUVhENkxtNTNfcDhjMURMTWllM2drOG56cW9YLVFDRkhzUjJEdnhVUVVPYU9YOFdqY1ZmUDJha2xXYmhvVXJFLUNycVg4b3hCYkNWUUNXNU16b3praGhsRktzVjZvaFBKNEFQY0NWREUwSDUxbTdGalBhTThlajVfbFk5bXVqam91cXlnSGVud3Zack0zTmxvYzBmVTJwQWtFVUhkS2JfTlNGZDY3MUhB?oc=5","date":"2019-02-28","type":"trial","source":"PR Newswire","summary":"Aesculap Biologics, LLC Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of NOVOCART® 3D in Patients with Articular Cartilage Defects of the Knee - PR Newswire","headline":"Aesculap Biologics, LLC Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of NOVOCART® 3D in Patient","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}